RecruitingNot ApplicableNCT04533958

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy Monocentric, Comparative, Randomized, Open Study

Sponsor

Saint-Gregoire Private Hospital Center

Enrollment

60 participants

Start Date

Sep 28, 2020

Study Type

INTERVENTIONAL

Conditions

Metastatic Prostate Cancer

Summary

Prostate cancer is the first cancer in men. The treatment of metastatic prostate cancer with chemotherapy is based on the intravenous administration of docetaxel chemotherapy. Symptoms of anticipatory nausea, linked to anxiety caused by the treatment, may occur. Hypnosis is already used to treat the anxiety of people with cancer and can help treat the symtoms of nausea and vomiting of women with breast cancer. The purpose of the study is to evaluate the effect of medical hypnosis in virtual reality on the anxiety of patients with metastatic prostate cancer receiving Docetaxel chemotherapy treatment in comparison with a control group.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether virtual reality hypnosis sessions can reduce anxiety in men with metastatic prostate cancer who are undergoing chemotherapy. **You may be eligible if...** - You are a man aged 18 or older - You have been diagnosed with metastatic prostate adenocarcinoma (confirmed by tissue biopsy) - You are receiving 12 rounds of docetaxel chemotherapy (every two weeks) - You are being treated and followed at the study center for up to 6 months **You may NOT be eligible if...** - You are enrolled in another clinical trial testing an experimental drug - You have previously received chemotherapy for prostate cancer - You are unable to attend study visits for personal, social, or geographic reasons - You have a serious underlying health condition that is incompatible with the study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHYPNO VR® device

The HYPNO VR® device is a software application of medical hypnosis in the treatment of pain and anxiety. It is associated with equipment: a virtual reality headset and a headphone. Before each Docetaxel infusion, the nursing staff offers patients the choices: visual universe, musical theme, male or female voice. The nursing staff selects the chemotherapy program, selects a duration of 20 minutes and presses start to start the medical hypnosis session in virtual reality. After completing the hypnotic trance sequence, as in a classic session, the patient is brought back to the "return" and exit hypnosis phase under the supervision of the nursing staff.